1. Home
  2. STVN vs STUB Comparison

STVN vs STUB Comparison

Compare STVN & STUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • STUB
  • Stock Information
  • Founded
  • STVN 1949
  • STUB 2000
  • Country
  • STVN Italy
  • STUB United States
  • Employees
  • STVN N/A
  • STUB N/A
  • Industry
  • STVN Containers/Packaging
  • STUB Services-Misc. Amusement & Recreation
  • Sector
  • STVN Consumer Discretionary
  • STUB Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • STUB Nasdaq
  • Market Cap
  • STVN 7.4B
  • STUB 6.4B
  • IPO Year
  • STVN 2021
  • STUB 2025
  • Fundamental
  • Price
  • STVN $22.87
  • STUB $11.88
  • Analyst Decision
  • STVN Buy
  • STUB Buy
  • Analyst Count
  • STVN 4
  • STUB 11
  • Target Price
  • STVN $25.88
  • STUB $25.00
  • AVG Volume (30 Days)
  • STVN 360.6K
  • STUB 4.7M
  • Earning Date
  • STVN 11-06-2025
  • STUB 11-13-2025
  • Dividend Yield
  • STVN 0.27%
  • STUB N/A
  • EPS Growth
  • STVN 19.61
  • STUB N/A
  • EPS
  • STVN 0.60
  • STUB N/A
  • Revenue
  • STVN $1,373,219,524.00
  • STUB $1,829,430,000.00
  • Revenue This Year
  • STVN $8.33
  • STUB $3.01
  • Revenue Next Year
  • STVN $10.12
  • STUB $55.81
  • P/E Ratio
  • STVN $38.31
  • STUB N/A
  • Revenue Growth
  • STVN 6.97
  • STUB 14.90
  • 52 Week Low
  • STVN $17.81
  • STUB $9.83
  • 52 Week High
  • STVN $28.00
  • STUB $27.89
  • Technical
  • Relative Strength Index (RSI)
  • STVN 45.20
  • STUB N/A
  • Support Level
  • STVN $20.67
  • STUB N/A
  • Resistance Level
  • STVN $24.01
  • STUB N/A
  • Average True Range (ATR)
  • STVN 1.23
  • STUB 0.00
  • MACD
  • STVN 0.06
  • STUB 0.00
  • Stochastic Oscillator
  • STVN 45.08
  • STUB 0.00

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About STUB StubHub Holdings Inc. Class A Common Stock

Stubhub Holdings Inc is an online marketplace for secondary ticket buy and selling.

Share on Social Networks: